Blood thinner safety tracked in kids after major heart surgery
NCT ID NCT06193863
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 21 times
Summary
This study follows children with congenital heart disease who have had the Fontan procedure and are prescribed rivaroxaban, a blood thinner, to prevent dangerous clots. Researchers will track bleeding events and other side effects using data from regular doctor visits. The goal is to better understand the drug's safety in real-world use, especially in Japanese children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.